外周血涂片骨髓细胞形态及骨髓活检联合检测对骨髓增生异常综合征的诊断价值

doi:10.3969/j.issn.1006-6233.2021.06.06

Abstract
Figure/Table
References
Related Citation (0)

Download: PDF (1222 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To investigate the diagnostic value of combined detection of peripheral blood smear, bone marrow cell morphology and bone marrow biopsy for myelodysplastic syndrome (MDS), aiming at providing reference for early diagnosis and treatment of MDS. Methods: 108 patients with suspected MDS admitted to the hospital from January 2016 to January 2020 were selected as subjects. All patients underwent peripheral blood smear, detection of bone marrow cell morphology and bone marrow biopsy. With follow-up data as the golden standard, the value of combined detection of peripheral blood smear, bone marrow cell morphology and bone marrow biopsy for diagnosis and classification of MDS was evaluated. Results: The efficiency (Kappa value) of combined detection of peripheral blood smear, bone marrow cell morphology and bone marrow biopsy in the diagnosis of MDS was higher than that of single detection. The sensitivity was significantly higher than that of single detection(P<0.05). With follow-up data as the golden standard, the accuracy of combined detection of peripheral blood smear, bone marrow cell morphology and bone marrow biopsy for classification of MDS was 84.62%(66/78). Conclusion: The combination detection of peripheral blood smear, bone marrow cell morphology and bone marrow biopsy can effectively improve the diagnostic sensitivity and accuracy for MDS. The accuracy of combined detection is also high in the classification of MDS. It is expected to provide reference for selection of treatment plan for MDS and prognosis evaluation.

Key words： Bone marrow cell morphology Peripheral blood smear Bone marrow biopsy Myelodysplastic syndrome

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHU Xiaohua
	WANG Jiancheng
	CHENG Yan
	et al

Cite this article:

ZHU Xiaohua,WANG Jiancheng,CHENG Yan, et al. Diagnostic Value of Combined Detection of Peripheral Blood Smear Bone Marrow Cell Morphology and Bone Marrow Biopsy for Myelodysplastic Syndrome[J]. HeBei Med, 2021, 27(6): 906-909.

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2021.06.06 OR http://www.hbyxzzs.cn/EN/Y2021/V27/I6/906

[1] Yuanyuan Ma,Jianliang Shen,Li-Xin Wang.Successful treatment of high-risk myelodysplastic syndrome with decitabine-based chemotherapy followed by haploidentical lymphocyte infusion:A case report and literature review[J].Medicine,2018,97(16):e0434.
[2] 刘林,徐欢,陈志妹,等.515例急性髓系白血病患者年龄特异的细胞遗传学分析[J].中华医学遗传学杂志,2019,36(6):552~555.
[3] 中华医学会血液学分会.骨髓增生异常综合征中国诊断与治疗指南(2019年版)[J].中华血液学杂志,2019,40(2):89~97.
[4] 吴蔚,顾健,倪军,等.多指标检测在骨髓增生异常综合征诊断中的应用评估[J].中华全科医学,2017,15(12):2120~2123,2151.
[5] 李燕,黄琴,王增胜,等.先后以自身免疫性溶血性贫血及纯红细胞再生障碍为表现的慢性B淋巴细胞增殖性疾病一例并文献复习[J].肿瘤研究与临床,2017,29(2):126~128.
[6] 钱小鸿,吴佳洛.骨髓增生异常综合征与巨幼细胞性贫血、再生障碍性贫血的细胞形态学对比分析[J].中国卫生检验杂志,2019,29(6):740~743.
[7] 孟祥永.骨髓增生异常综合征239例临床病例分析[D].山东大学,2017.
[8] 肖志坚.骨髓增生异常综合征诊断的方法学:现况与问题[J].国际输血及血液学杂志,2019,42(2):93~97.
[9] 宋晓颖,袁宝军,崔晶晶,等.骨髓增生异常综合征患者红细胞参数水平变化及临床意义[J].国际检验医学杂志,2020,41(13):1629~1631,1635.
[10] 薛宏怡,竺枫,王宏强,等.骨髓活检与涂片对全血细胞减少症的诊断一致性研究[J].浙江医学,2019,41(12):1320~1321.
[11] 谢春艳,牟娜,多亚莉,等.五项技术联检对骨髓增生异常综合征诊断价值的初步探讨[J].中国实验血液学杂志,2016,24(2):515~518.
[12] 江亚军,庄万传,朱贵华,等.血细胞减少或增多患者骨髓穿刺干抽的相关原因分析[J].白血病·淋巴瘤,2018,27(9):539~542.
[13] Valent Peter,Orazi Attilio,Busche Guntram,et al.Standards and impact of hematopathology in myelodysplastic syndromes(MDS)[J].2010,1(7):483~496.
[14] Jean A,Ridgeway,DNP,et al.Practical guide to bone marrow sampling for suspected myelodysplastic syndromes[J].Journal of the Advanced Practitioner in Oncology,2017,8(1):29~39.